US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Eupraxia Pharmaceuticals

6.46

0.0000

Volume:90.64K

Turnover:582.92K

Market Cap:426.83M

PE:-6.48

High:6.53

Open:6.42

Low:6.33

Close:6.46

52wk High:9.32

52wk Low:5.15

Shares:66.07M

Float Shares:54.50M

Volume Ratio:0.45

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9967

EPS(LYR):-1.0300

ROE:-66.70%

ROA:-43.66%

PB:4.19

PE(LYR):-6.27

Loading ...

Overview Company News Filings

Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Stifel Initiates Eupraxia Pharmaceuticals at Buy With CA$34.37 Price Target

MT Newswires Live

Eupraxia Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25

THOMSON REUTERS

Eupraxia Pharmaceuticals initiated with a Buy at Stifel

Eupraxia Pharmaceuticals Reports Stronger Balance Sheet but Wider Q1 2026 Loss in Form 6-K Filing

Eupraxia Pharmaceuticals reports Q1 net loss ($12.7M) vs. ($6.8M) last year

Eupraxia Pharmaceuticals Q1 EPS $(0.23) Misses $(0.22) Estimate

Benzinga Earnings

Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)

Eupraxia Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)

Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer

Eupraxia Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting

Craig-Hallum Sticks to Their Buy Rating for Eupraxia Pharmaceuticals (EPRX)

Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis

Eupraxia Pharmaceuticals to Highlight Drug-Delivery Pipeline at April Investor Conferences

Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences

Eupraxia Pharmaceuticals (EPRX) Receives a Buy from Cantor Fitzgerald

Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst

Benzinga_recent_news

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/EPRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPRX\",,,,,undefined,":{"symbol":"EPRX","market":"US","secType":"STK","nameCN":"Eupraxia Pharmaceuticals","latestPrice":6.46,"timestamp":1788284680318,"preClose":6.46,"halted":0,"volume":90642,"delay":0,"changeRate":0,"floatShares":54496455,"shares":66073400,"eps":-0.996725,"marketStatus":"Trading","change":0,"latestTime":"09-01 13:45:53 EDT","open":6.42,"high":6.53,"low":6.33,"amount":582923.8232730001,"amplitude":0.03096,"askPrice":6.46,"askSize":382,"bidPrice":6.45,"bidSize":72,"shortable":3,"etf":0,"ttmEps":-0.996725,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1712289600000,"exchange":"NASDAQ","adjPreClose":6.46,"preHourTrading":{"tag":"盘前","latestPrice":6.71,"preClose":6.46,"latestTime":"09:19 EDT","volume":11540,"amount":74742.001964,"timestamp":1788268746513,"change":0.25,"changeRate":0.0387,"amplitude":0.137771},"postHourTrading":{"tag":"盘后","latestPrice":6.46,"preClose":6.46,"latestTime":"19:59 EDT","volume":115,"amount":744.3,"timestamp":1788220772590,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.445011},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPRX\",,,,,undefined,":{"symbol":"EPRX","floatShares":54496455,"roa":"-43.66%","roe":"-66.70%","lyrEps":-1.03,"volumeRatio":0.445011,"shares":66073400,"dividePrice":0,"high":6.53,"amplitude":0.03096,"preClose":6.46,"low":6.33,"week52Low":5.1501,"pbRate":"4.19","week52High":9.32,"institutionHeld":0,"latestPrice":6.46,"committee":-0.682819,"eps":-0.996725,"divideRate":0,"volume":90642,"delay":0,"ttmEps":-0.996725,"open":6.42,"prevYearClose":7.55,"prevWeekClose":6.675,"prevMonthClose":6.46,"prevQuarterClose":6.61,"fiveDayClose":7.42,"twentyDayClose":6.52,"sixtyDayClose":5.95},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"EPRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.25,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2026-05-12","symbol":"EPRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.22,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2026-03-12","symbol":"EPRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.16,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-11-04","symbol":"EPRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"EPRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.21,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EPRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1782619200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EPRX","date":"2026-08-31","current":-6.481226,"percent":0.376667,"low":-17.474426,"twenty":-10.686673,"median":-5.907221,"eighty":-3.508398,"high":-2.890365,"avg":-7.166514,"sd":3.781085,"marketCap":441163433.87},"quantilePoints":[{"date":"2024-04-12","current":-3.449431,"twenty":-3.612259,"median":-3.541416,"eighty":-3.493027,"marketCap":97345692.17},{"date":"2024-04-19","current":-3.387698,"twenty":-3.552309,"median":-3.421661,"eighty":-3.370461,"marketCap":95603540.57},{"date":"2024-04-26","current":-3.593562,"twenty":-3.625516,"median":-3.503926,"eighty":-3.385892,"marketCap":101413189.09},{"date":"2024-05-03","current":-3.426605,"twenty":-3.600947,"median":-3.43788,"eighty":-3.383971,"marketCap":96701521.5},{"date":"2024-05-10","current":-3.385898,"twenty":-3.641329,"median":-3.449431,"eighty":-3.385721,"marketCap":102824445.35},{"date":"2024-05-17","current":-3.411647,"twenty":-3.640071,"median":-3.447632,"eighty":-3.387338,"marketCap":103606411.08},{"date":"2024-05-24","current":-3.304959,"twenty":-3.624933,"median":-3.446108,"eighty":-3.385721,"marketCap":100366460.1},{"date":"2024-05-31","current":-3.138144,"twenty":-3.606012,"median":-3.426605,"eighty":-3.379346,"marketCap":95300524.8},{"date":"2024-06-07","current":-3.18109,"twenty":-3.59449,"median":-3.400672,"eighty":-3.300706,"marketCap":96604762.18},{"date":"2024-06-14","current":-3.114449,"twenty":-3.562274,"median":-3.394505,"eighty":-3.199957,"marketCap":94580945.94},{"date":"2024-06-21","current":-3.113503,"twenty":-3.52642,"median":-3.387698,"eighty":-3.149669,"marketCap":94552230.25},{"date":"2024-06-28","current":-2.999703,"twenty":-3.496261,"median":-3.38264,"eighty":-3.125012,"marketCap":91096288.31},{"date":"2024-07-05","current":-3.012181,"twenty":-3.47937,"median":-3.379233,"eighty":-3.113445,"marketCap":91475249.09},{"date":"2024-07-12","current":-3.187556,"twenty":-3.456124,"median":-3.305072,"eighty":-3.105179,"marketCap":96801126.62},{"date":"2024-07-19","current":-2.929989,"twenty":-3.449376,"median":-3.282654,"eighty":-3.095065,"marketCap":88979206.08},{"date":"2024-07-26","current":-3.134177,"twenty":-3.44886,"median":-3.212535,"eighty":-3.063005,"marketCap":95180061.81},{"date":"2024-08-02","current":-3.030624,"twenty":-3.447364,"median":-3.22865,"eighty":-3.063005,"marketCap":92035318.44},{"date":"2024-08-09","current":-3.555022,"twenty":-3.447364,"median":-3.244765,"eighty":-3.058864,"marketCap":95980604.85},{"date":"2024-08-16","current":-3.425897,"twenty":-3.447364,"median":-3.274173,"eighty":-3.063005,"marketCap":92494393.43},{"date":"2024-08-23","current":-3.341671,"twenty":-3.449376,"median":-3.294326,"eighty":-3.065374,"marketCap":90220410.26},{"date":"2024-08-30","current":-3.353652,"twenty":-3.464811,"median":-3.315197,"eighty":-3.071687,"marketCap":90543888.67},{"date":"2024-09-06","current":-3.290695,"twenty":-3.457797,"median":-3.315197,"eighty":-3.093069,"marketCap":88844129.04},{"date":"2024-09-13","current":-3.351624,"twenty":-3.449431,"median":-3.304959,"eighty":-3.103048,"marketCap":90489126.39},{"date":"2024-09-20","current":-3.738594,"twenty":-3.484763,"median":-3.331473,"eighty":-3.103161,"marketCap":100936771.57},{"date":"2024-09-27","current":-3.383135,"twenty":-3.508398,"median":-3.341671,"eighty":-3.113249,"marketCap":91339879.21},{"date":"2024-10-04","current":-3.46667,"twenty":-3.50577,"median":-3.366161,"eighty":-3.11343,"marketCap":93595226.49},{"date":"2024-10-11","current":-3.161762,"twenty":-3.503926,"median":-3.341671,"eighty":-3.113249,"marketCap":85363132.94},{"date":"2024-10-18","current":-3.344907,"twenty":-3.484763,"median":-3.339004,"eighty":-3.11343,"marketCap":90307790.09},{"date":"2024-10-25","current":-3.261872,"twenty":-3.467153,"median":-3.321915,"eighty":-3.113503,"marketCap":88065960.81},{"date":"2024-11-01","current":-4.073023,"twenty":-3.467153,"median":-3.311841,"eighty":-3.114449,"marketCap":109965883.2},{"date":"2024-11-08","current":-3.993124,"twenty":-3.508398,"median":-3.325322,"eighty":-3.122968,"marketCap":112688263.8},{"date":"2024-11-15","current":-3.927702,"twenty":-3.541416,"median":-3.341027,"eighty":-3.124574,"marketCap":110842028.91},{"date":"2024-11-22","current":-4.430924,"twenty":-3.593562,"median":-3.351624,"eighty":-3.128079,"marketCap":125043241.56},{"date":"2024-11-29","current":-4.297671,"twenty":-3.603509,"median":-3.37867,"eighty":-3.132957,"marketCap":121282763.27},{"date":"2024-12-06","current":-3.937318,"twenty":-3.628014,"median":-3.3817,"eighty":-3.136354,"marketCap":111113399.77},{"date":"2024-12-13","current":-4.300289,"twenty":-3.656263,"median":-3.385015,"eighty":-3.137895,"marketCap":121356641.03},{"date":"2024-12-20","current":-3.802924,"twenty":-3.703016,"median":-3.386798,"eighty":-3.142303,"marketCap":107320735.58},{"date":"2024-12-27","current":-3.93234,"twenty":-3.764328,"median":-3.391081,"eighty":-3.149279,"marketCap":110972914.73},{"date":"2025-01-03","current":-3.832661,"twenty":-3.83089,"median":-3.39476,"eighty":-3.153681,"marketCap":108159910.78},{"date":"2025-01-10","current":-3.777243,"twenty":-3.823171,"median":-3.399132,"eighty":-3.154763,"marketCap":106595986.62},{"date":"2025-01-17","current":-4.056922,"twenty":-3.839064,"median":-3.402373,"eighty":-3.156968,"marketCap":114488699.15},{"date":"2025-01-24","current":-3.831634,"twenty":-3.855819,"median":-3.411647,"eighty":-3.159158,"marketCap":108130926.13},{"date":"2025-01-31","current":-3.881124,"twenty":-3.855819,"median":-3.426251,"eighty":-3.159259,"marketCap":109527578.75},{"date":"2025-02-07","current":-4.05521,"twenty":-3.863924,"median":-3.433627,"eighty":-3.159948,"marketCap":114440377.27},{"date":"2025-02-14","current":-4.035949,"twenty":-3.899488,"median":-3.442651,"eighty":-3.161762,"marketCap":113896828.09},{"date":"2025-02-21","current":-4.691735,"twenty":-3.92863,"median":-3.448417,"eighty":-3.164244,"marketCap":132403473.98},{"date":"2025-02-28","current":-4.985728,"twenty":-3.942572,"median":-3.453351,"eighty":-3.171739,"marketCap":140700111.56},{"date":"2025-03-07","current":-5.272628,"twenty":-3.973604,"median":-3.466617,"eighty":-3.179564,"marketCap":148796613.2},{"date":"2025-03-14","current":-5.235352,"twenty":-4.013632,"median":-3.484763,"eighty":-3.186263,"marketCap":147744675.63},{"date":"2025-03-21","current":-5.143943,"twenty":-4.046869,"median":-3.507084,"eighty":-3.193275,"marketCap":131183594.48},{"date":"2025-03-28","current":-4.683166,"twenty":-4.084769,"median":-3.523754,"eighty":-3.206159,"marketCap":119432606.84},{"date":"2025-04-04","current":-4.101903,"twenty":-4.144484,"median":-3.54588,"eighty":-3.211833,"marketCap":104608925.61},{"date":"2025-04-11","current":-4.181878,"twenty":-4.156687,"median":-3.555418,"eighty":-3.233723,"marketCap":106648501.77},{"date":"2025-04-17","current":-4.623736,"twenty":-4.175739,"median":-3.595883,"eighty":-3.239438,"marketCap":117916996.55},{"date":"2025-04-25","current":-5.41667,"twenty":-4.199429,"median":-3.609908,"eighty":-3.239815,"marketCap":138138823.95},{"date":"2025-05-02","current":-5.613333,"twenty":-4.264738,"median":-3.621205,"eighty":-3.242792,"marketCap":143154231.65},{"date":"2025-05-09","current":-5.295999,"twenty":-4.315353,"median":-3.640408,"eighty":-3.244752,"marketCap":138872234.38},{"date":"2025-05-16","current":-5.22877,"twenty":-4.436885,"median":-3.652794,"eighty":-3.248222,"marketCap":137109346.32},{"date":"2025-05-23","current":-5.086528,"twenty":-4.497055,"median":-3.683127,"eighty":-3.254144,"marketCap":133379475.66},{"date":"2025-05-30","current":-5.353206,"twenty":-4.57142,"median":-3.705394,"eighty":-3.256702,"marketCap":140372329.16},{"date":"2025-06-06","current":-5.498899,"twenty":-4.688307,"median":-3.727372,"eighty":-3.257371,"marketCap":144192703.66},{"date":"2025-06-13","current":-5.361342,"twenty":-4.755446,"median":-3.735365,"eighty":-3.25942,"marketCap":140585698.02},{"date":"2025-06-20","current":-6.021317,"twenty":-4.844055,"median":-3.755654,"eighty":-3.26156,"marketCap":157891599.42},{"date":"2025-06-27","current":-6.394464,"twenty":-4.984149,"median":-3.780835,"eighty":-3.263694,"marketCap":167676310.99},{"date":"2025-07-03","current":-7.487464,"twenty":-5.086528,"median":-3.792925,"eighty":-3.270982,"marketCap":196337074.41},{"date":"2025-07-11","current":-7.62232,"twenty":-5.143943,"median":-3.801523,"eighty":-3.275156,"marketCap":199873266.74},{"date":"2025-07-18","current":-7.38883,"twenty":-5.177531,"median":-3.819467,"eighty":-3.277364,"marketCap":193750685.21},{"date":"2025-07-25","current":-7.574057,"twenty":-5.210176,"median":-3.832148,"eighty":-3.277562,"marketCap":198607730.41},{"date":"2025-08-01","current":-7.369401,"twenty":-5.244258,"median":-3.855819,"eighty":-3.290209,"marketCap":193241210.3},{"date":"2025-08-08","current":-7.353701,"twenty":-5.256616,"median":-3.862136,"eighty":-3.290695,"marketCap":192829519.9},{"date":"2025-08-15","current":-6.515547,"twenty":-5.287548,"median":-3.881124,"eighty":-3.293384,"marketCap":188662911.97},{"date":"2025-08-22","current":-6.435294,"twenty":-5.330379,"median":-3.902951,"eighty":-3.294326,"marketCap":186339119.08},{"date":"2025-08-29","current":-6.443249,"twenty":-5.361342,"median":-3.927702,"eighty":-3.29841,"marketCap":186569475.43},{"date":"2025-09-05","current":-6.594946,"twenty":-5.398376,"median":-3.933623,"eighty":-3.303649,"marketCap":190961969.86},{"date":"2025-09-12","current":-6.795439,"twenty":-5.448392,"median":-3.947836,"eighty":-3.305049,"marketCap":196767403.48},{"date":"2025-09-19","current":-7.504554,"twenty":-5.562315,"median":-3.961669,"eighty":-3.315902,"marketCap":217300397.06},{"date":"2025-09-26","current":-7.177732,"twenty":-5.598125,"median":-3.989698,"eighty":-3.321254,"marketCap":207837019.06},{"date":"2025-10-03","current":-10.41009,"twenty":-5.766572,"median":-4.012411,"eighty":-3.324641,"marketCap":301432553.8},{"date":"2025-10-10","current":-10.720754,"twenty":-6.007438,"median":-4.037645,"eighty":-3.335164,"marketCap":310428066.15},{"date":"2025-10-17","current":-10.15161,"twenty":-6.40263,"median":-4.05521,"eighty":-3.339831,"marketCap":293948056.76},{"date":"2025-10-24","current":-9.839558,"twenty":-6.476402,"median":-4.069956,"eighty":-3.341413,"marketCap":284912320.02},{"date":"2025-10-31","current":-9.373299,"twenty":-6.573065,"median":-4.13169,"eighty":-3.34426,"marketCap":271411444.71},{"date":"2025-11-07","current":-9.699849,"twenty":-6.613334,"median":-4.138877,"eighty":-3.350281,"marketCap":284921875.51},{"date":"2025-11-14","current":-10.803812,"twenty":-6.67166,"median":-4.151036,"eighty":-3.353246,"marketCap":317349508.66},{"date":"2025-11-21","current":-10.8778,"twenty":-6.689916,"median":-4.163525,"eighty":-3.373666,"marketCap":319522857.51},{"date":"2025-11-28","current":-10.814452,"twenty":-6.746599,"median":-4.176559,"eighty":-3.379346,"marketCap":317662080.57},{"date":"2025-12-05","current":-9.965856,"twenty":-6.97961,"median":-4.181878,"eighty":-3.380077,"marketCap":292735526.92},{"date":"2025-12-12","current":-11.086677,"twenty":-7.160673,"median":-4.205443,"eighty":-3.381987,"marketCap":325658373.25},{"date":"2025-12-19","current":-10.90031,"twenty":-7.261302,"median":-4.255979,"eighty":-3.383716,"marketCap":320184040.95},{"date":"2025-12-26","current":-12.631802,"twenty":-7.339109,"median":-4.297671,"eighty":-3.384468,"marketCap":371044617.8},{"date":"2026-01-02","current":-12.965446,"twenty":-7.369059,"median":-4.309912,"eighty":-3.385184,"marketCap":380845039.89},{"date":"2026-01-09","current":-14.785144,"twenty":-7.418048,"median":-4.386192,"eighty":-3.385869,"marketCap":434296571.54},{"date":"2026-01-16","current":-15.389028,"twenty":-7.520623,"median":-4.445826,"eighty":-3.386258,"marketCap":452034968.62},{"date":"2026-01-23","current":-15.580982,"twenty":-7.574388,"median":-4.464922,"eighty":-3.387698,"marketCap":457673379.52},{"date":"2026-01-30","current":-14.457625,"twenty":-7.65829,"median":-4.510416,"eighty":-3.38827,"marketCap":424676100},{"date":"2026-02-06","current":-14.5446,"twenty":-7.863135,"median":-4.596564,"eighty":-3.393892,"marketCap":427230871.96},{"date":"2026-02-13","current":-13.989424,"twenty":-9.489561,"median":-4.653451,"eighty":-3.394505,"marketCap":410923224.77},{"date":"2026-02-20","current":-16.390125,"twenty":-9.557651,"median":-4.695082,"eighty":-3.394913,"marketCap":481441025.08},{"date":"2026-02-27","current":-16.802164,"twenty":-9.685229,"median":-4.72791,"eighty":-3.39818,"marketCap":493544204.69},{"date":"2026-03-06","current":-16.121449,"twenty":-9.854571,"median":-4.82528,"eighty":-3.399229,"marketCap":473548992.17},{"date":"2026-03-13","current":-15.341881,"twenty":-10.108464,"median":-4.914889,"eighty":-3.399741,"marketCap":450650085.89},{"date":"2026-03-20","current":-12.207037,"twenty":-10.222708,"median":-4.98178,"eighty":-3.401869,"marketCap":470900399.6},{"date":"2026-03-27","current":-10.868902,"twenty":-10.325166,"median":-5.050563,"eighty":-3.407507,"marketCap":419280306.63},{"date":"2026-04-02","current":-11.812752,"twenty":-10.428995,"median":-5.086528,"eighty":-3.410504,"marketCap":455690426.23},{"date":"2026-04-10","current":-11.244095,"twenty":-10.531382,"median":-5.122409,"eighty":-3.417155,"marketCap":433753837.31},{"date":"2026-04-17","current":-11.429195,"twenty":-10.646926,"median":-5.156117,"eighty":-3.423869,"marketCap":440894263.63},{"date":"2026-04-24","current":-11.641458,"twenty":-10.704704,"median":-5.181719,"eighty":-3.426322,"marketCap":449082540.05},{"date":"2026-05-01","current":-12.473837,"twenty":-10.761548,"median":-5.205938,"eighty":-3.430711,"marketCap":481192508.93},{"date":"2026-05-08","current":-11.981921,"twenty":-10.810847,"median":-5.230455,"eighty":-3.433556,"marketCap":462216320.35},{"date":"2026-05-15","current":-10.000865,"twenty":-10.850923,"median":-5.244258,"eighty":-3.436509,"marketCap":444708135.76},{"date":"2026-05-22","current":-10.368446,"twenty":-10.8274,"median":-5.25364,"eighty":-3.438888,"marketCap":461053344.94},{"date":"2026-05-29","current":-10.854641,"twenty":-10.856101,"median":-5.264622,"eighty":-3.441959,"marketCap":482672967.96},{"date":"2026-06-05","current":-9.542844,"twenty":-10.851513,"median":-5.277853,"eighty":-3.446736,"marketCap":424341321.14},{"date":"2026-06-12","current":-8.832946,"twenty":-10.833874,"median":-5.301083,"eighty":-3.448269,"marketCap":392774285.76},{"date":"2026-06-18","current":-9.167852,"twenty":-10.81325,"median":-5.32446,"eighty":-3.449211,"marketCap":407666550.16},{"date":"2026-06-26","current":-9.440409,"twenty":-10.807518,"median":-5.353206,"eighty":-3.450215,"marketCap":419786335.04},{"date":"2026-07-02","current":-9.641771,"twenty":-10.803812,"median":-5.361342,"eighty":-3.453351,"marketCap":428740325.4},{"date":"2026-07-10","current":-10.162415,"twenty":-10.767552,"median":-5.38351,"eighty":-3.457797,"marketCap":451891749.96},{"date":"2026-07-17","current":-9.083126,"twenty":-10.766643,"median":-5.418769,"eighty":-3.466564,"marketCap":403899038.4},{"date":"2026-07-24","current":-9.236419,"twenty":-10.758152,"median":-5.449312,"eighty":-3.46667,"marketCap":410715527.52},{"date":"2026-07-31","current":-9.540913,"twenty":-10.728799,"median":-5.498302,"eighty":-3.467056,"marketCap":424255446.68},{"date":"2026-08-07","current":-9.767697,"twenty":-10.720895,"median":-5.583439,"eighty":-3.481241,"marketCap":434339843.08},{"date":"2026-08-14","current":-8.697761,"twenty":-10.714049,"median":-5.59107,"eighty":-3.500093,"marketCap":436740727.51},{"date":"2026-08-21","current":-8.881205,"twenty":-10.702148,"median":-5.613333,"eighty":-3.505401,"marketCap":445951988.91},{"date":"2026-08-28","current":-9.629108,"twenty":-10.689257,"median":-5.819316,"eighty":-3.507872,"marketCap":483506421.55},{"date":"2026-08-31","current":-8.78584,"twenty":-10.686673,"median":-5.907221,"eighty":-3.508398,"marketCap":441163433.87}],"updateTime":1788284753689},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638469817","title":"Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638469817","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638469817?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969600,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, May  28, 2026  (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (\"Eupraxia\" or the \"Company\") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/28/3302790/0/en/Eupraxia-Pharmaceuticals-to-Participate-in-the-Jefferies-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","LU0029874061.USD","BK4585","LABU","LU0128526141.USD","XBI","EPRX","BK4137","HCSG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637380942","title":"Stifel Initiates Eupraxia Pharmaceuticals at Buy With CA$34.37 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380942","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637380942?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:06","pubTimestamp":1779361605,"startTime":"0","endTime":"0","summary":"Eupraxia Pharmaceuticals (EPRX) has an average rating of buy and mean price target of CA$21.74, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","CA","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637387730","title":"Eupraxia Pharmaceuticals Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2637387730","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637387730?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:58","pubTimestamp":1779361082,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EPRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637780008","title":"Eupraxia Pharmaceuticals initiated with a Buy at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2637780008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637780008?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:15","pubTimestamp":1779308141,"startTime":"0","endTime":"0","summary":"Stifel initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy rating and $25 price target Eupraxia is validating its Diffusphere platform...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eupraxia-pharmaceuticals-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eupraxia-pharmaceuticals-initiated-with-a-buy-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPRX","BK4127","BK4139","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635260722","title":"Eupraxia Pharmaceuticals Reports Stronger Balance Sheet but Wider Q1 2026 Loss in Form 6-K Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635260722","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635260722?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:45","pubTimestamp":1778625904,"startTime":"0","endTime":"0","summary":"An update from Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) is now available. Eupraxia Pharmaceuticals filed a Form 6-K for May 2026, providing unaudit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eupraxia-pharmaceuticals-reports-stronger-balance-sheet-but-wider-q1-2026-loss-in-form-6-k-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eupraxia-pharmaceuticals-reports-stronger-balance-sheet-but-wider-q1-2026-loss-in-form-6-k-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635226463","title":"Eupraxia Pharmaceuticals reports Q1 net loss ($12.7M) vs. ($6.8M) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2635226463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635226463?lang=en_us&edition=fundamental","pubTime":"2026-05-13 06:31","pubTimestamp":1778625086,"startTime":"0","endTime":"0","summary":"The Company had cash and cash equivalents of $58.5M and short-term investments of $80.4M as of March 31, up from a cash balance of $80.6M at the en...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eupraxia-pharmaceuticals-reports-q1-net-loss-12-7m-vs-6-8m-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eupraxia-pharmaceuticals-reports-q1-net-loss-12-7m-vs-6-8m-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223511","title":"Eupraxia Pharmaceuticals Q1 EPS $(0.23) Misses $(0.22) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223511","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223511?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:08","pubTimestamp":1778620104,"startTime":"0","endTime":"0","summary":"Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 9.52 percent decrease over losses of $(0.21) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52509029/eupraxia-pharmaceuticals-q1-eps-0-23-misses-0-22-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Eupraxia Pharmaceuticals Q1 EPS $(0.23) Misses $(0.22) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223517","title":"Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223517","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223517?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:00","pubTimestamp":1778619600,"startTime":"0","endTime":"0","summary":"Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI Completion of a $63.2 million public offering to enable clinical trials of EP-104GI in additional indicat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293518/0/en/Eupraxia-Pharmaceuticals-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633914036","title":"Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633914036","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633914036?lang=en_us&edition=fundamental","pubTime":"2026-05-05 19:00","pubTimestamp":1777978800,"startTime":"0","endTime":"0","summary":"EREFS is a standardized visual scoring system that gastroenterologists use when performing an endoscopy in EoE patients to assess the severity of inflammation and fibrosis in the esophagus EREFS data ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/05/3287509/0/en/Eupraxia-Pharmaceuticals-Reports-EREFS-Data-from-its-Ongoing-Phase-1b-2a-RESOLVE-Trial-in-Eosinophilic-Esophagitis-at-Digestive-Disease-Week-DDW.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633892957","title":"Eupraxia Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633892957","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633892957?lang=en_us&edition=fundamental","pubTime":"2026-05-05 00:58","pubTimestamp":1777913880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 04, 2026 12:58 ET (16:58 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632548079","title":"H.C. Wainwright Remains a Buy on Eupraxia Pharmaceuticals (EPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632548079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632548079?lang=en_us&edition=fundamental","pubTime":"2026-05-04 23:15","pubTimestamp":1777907716,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Eupraxia Pharmaceuticals today and set a price target of $11.00. According to Tip...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-eupraxia-pharmaceuticals-eprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-eupraxia-pharmaceuticals-eprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632400616","title":"Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2632400616","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632400616?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:05","pubTimestamp":1777669500,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, May  01, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (\"Eupraxia\" or the \"Company\") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/01/3286252/0/en/Eupraxia-Pharmaceuticals-Appoints-Dr-Jeymi-Tambiah-as-Chief-Medical-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045996","title":"Eupraxia Pharmaceuticals Price Target Maintained With a $11.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045996?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:48","pubTimestamp":1776858480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EPRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 22, 2026 07:48 ET (11:48 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629100040","title":"Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629100040","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629100040?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, April  22, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (\"Eupraxia\" or the \"Company\") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/22/3278788/0/en/Eupraxia-Pharmaceuticals-to-Present-at-Digestive-Disease-Week-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629099184","title":"Craig-Hallum Sticks to Their Buy Rating for Eupraxia Pharmaceuticals (EPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629099184","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629099184?lang=en_us&edition=fundamental","pubTime":"2026-04-22 12:47","pubTimestamp":1776833228,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Albert Lowe from Craig-Hallum maintained a Buy rating on Eupraxia Pharmaceuticals. The company’s shares closed yest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-eupraxia-pharmaceuticals-eprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-eupraxia-pharmaceuticals-eprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629033663","title":"Eupraxia Pharmaceuticals Reports Positive Nine-Month Tissue Health and Symptom Data from the Highest Dose Cohort in its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629033663","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629033663?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:00","pubTimestamp":1776769200,"startTime":"0","endTime":"0","summary":"This is the first release of 36-week symptom response & tissue health data for the highest dose (Cohort 9) from the dose escalation portion of Eupraxia’s RESOLVE trial.At 36 weeks, patients in Cohort ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3277764/0/en/Eupraxia-Pharmaceuticals-Reports-Positive-Nine-Month-Tissue-Health-and-Symptom-Data-from-the-Highest-Dose-Cohort-in-its-Ongoing-Phase-1b-2a-RESOLVE-Trial-in-Eosinophilic-Esophagiti.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627473562","title":"Eupraxia Pharmaceuticals to Highlight Drug-Delivery Pipeline at April Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2627473562","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627473562?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:08","pubTimestamp":1776211739,"startTime":"0","endTime":"0","summary":"Eupraxia Pharmaceuticals ( ($TSE:EPRX) ) has issued an announcement. Eupraxia Pharmaceuticals, a clinical-stage biotech specializing in locally del...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eupraxia-pharmaceuticals-to-highlight-drug-delivery-pipeline-at-april-investor-conferences?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eupraxia-pharmaceuticals-to-highlight-drug-delivery-pipeline-at-april-investor-conferences?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EPRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627589504","title":"Eupraxia Pharmaceuticals to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2627589504","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627589504?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:00","pubTimestamp":1776081600,"startTime":"0","endTime":"0","summary":"VICTORIA, British Columbia, April  13, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (\"Eupraxia\" or the \"Company\") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/13/3272444/0/en/Eupraxia-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624513009","title":"Eupraxia Pharmaceuticals (EPRX) Receives a Buy from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2624513009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624513009?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:16","pubTimestamp":1775045814,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Eupraxia Pharmaceuticals yesterday and set a price target of $19.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/eupraxia-pharmaceuticals-eprx-receives-a-buy-from-cantor-fitzgerald-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/eupraxia-pharmaceuticals-eprx-receives-a-buy-from-cantor-fitzgerald-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085647","title":"Eupraxia Pharmaceuticals Boasts $900 Million Peak Sales Potential: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085647","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621085647?lang=en_us&edition=fundamental","pubTime":"2026-03-24 01:59","pubTimestamp":1774288740,"startTime":"0","endTime":"0","summary":"William Blair starts Eupraxia at Outperform as the analyst flags unmet need and sizable market potential.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/23/X-ray-Anterior-Or-Front-View-Of-The-Esop.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/23/X-ray-Anterior-Or-Front-View-Of-The-Esop.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/03/51415703/eupraxia-pharmaceuticals-boasts-900-million-peak-sales-potential-analyst","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/03/51415703/eupraxia-pharmaceuticals-boasts-900-million-peak-sales-potential-analyst","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SKIS","EPRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":64,"code":"91000000","status":"200"}]}}